Long COVID Virtual Event: Recorded February 21, 2023
The recording is divided into Three Parts below:
This was the first meeting in a series of conferences cohosted by the Biotechnology Innovation Organization (BIO) and Solve M.E. that are designed to foster a private-public engagement and create an R&D roadmap for diagnostics and treatments for Long COVID and Post-infection Diseases.
Objective: Convene stakeholders to advance R&D to diagnose and treat Long COVID and post-infection diseases to:
- Increase awareness among drug developers to the unmet need and business opportunity in these indications
- Establish a knowledge base of emerging research in Long COVID and existing body of data in other post-infection diseases (such as dysautonomia, myalgic encephalomyelitis/ chronic fatigue syndrome, mast cell activation, and others).
- Highlight potential biological targets for therapeutic and preventative approaches
- Engage experts and regulators to inform design of clinical studies
- Establish a pre-competitive collaborative network
Hosted by:
—Cartier Esham, Ph.D., Chief Science Officer, Biotechnology Innovation Organization (BIO)
—Oved Amitay, RPh, MSc, President and CEO, Solve M.E.; Co-founder, Long Covid Alliance
Speakers
US Senator, Tim Kaine
Akiko Iwasaki, PhD, Sterling Professor of Immunobiology (Microbial Diseases), Yale School of Medicine
Amy Proal, PhD, Co-Founder, Science advisor, PolyBio
Bruce Patterson, MD, CEO & Founder, IncellDx
Christopher Austin, MD, CEO-Partner, Flagship Pioneering
David Putrino, PhD, Associate Professor, Rehabilitation and Human
Julie Gerberding, MD, MPH, CEO, Foundation for the National Institutes of Health
Katie Bach, MBA, Nonresident Senior Fellow, Brookings Institution
Lisa McCorkell, MPP, Co-Founder, Patient-Led Research Collaborative
Margaret Koziel, MD, SVP, Chief Medical Officer, Axcella Therapeutics
Michael VanElzakkar, PhD, Co-Founder, Science advisor, PolyBio; Massachusetts General Hospital
Priti Patel, MD, MPH, Senior Advisor for Post-COVID Conditions, Centers for Disease Control and Prevention
Rachel L. Levine, M.D., Admiral, U.S. Public Health Service, U.S. Department of Health and Human Services
Seth Lederman, MD, Co-Founder, CEO & Chairman, Tonix Pharmaceuticals
Thomas Equels, M.S., J.D., CEO, AIM Immunotech
Walter Koroshetz, MD, Director, National Institute of Neurological Disorders and Stroke (NINDS)
Click Here for a short list of some suggested readings of key publications authored by the speakers.
